At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 145 enrolled
Drug / intervention
botulinum toxin type A +1 morebiological
Likely dose
botulinum toxin type A 200 Unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia
In Brief
A Phase 4 clinical trial evaluating botulinum toxin type A for Spasmodic Torticollis. Completed, enrolled 145 participants across 5 sites in 5 countries.
Detailed Summary
The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpasmodic Torticollis
CountriesAustralia, Croatia, Italy, Poland, Turkey (Türkiye)
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedSep 2007
Primary CompletionSep 2009
TodayJul 2026
First PostedSep 12, 2007
Enrollment StartSep 1, 2007
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 18.8 years ago
Interventions
botulinum toxin type Abiological
200 Units at Visit 1 (Day 1)
botulinum toxin type Abiological
750 Units at Visit 1 (Day 1)